Explore our coaching, meal-planning tools, and protein-forward strategies designed to support fat loss while helping you stay strong, nourished, and consistent.
In a 68-week placebo-controlled trial, once-weekly semaglutide (Ozempic, Wegovy) injections in people with obesity and moderate knee osteoarthritis produced significantly greater reductions in body weight along with significant improvements in pain scores and better physical function
Less common but potentially serious risks may include pancreatitis (inflammation of the pancreas), gallbladder problems, kidney damage, allergic reactions, and thyroid tumors
14 A semaglutide and tirzepatide study in obese individuals yielded similar results, showing a reduction in alcohol intake, binge episodes, average drinks, and AUDIT scores
This dual benefit makes them an important option for tackling multiple health issues
This is the window where proactive management matters most